Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.66, $0.12 better than the analyst estimate of $0.54. Revenue for the quarter came in at $638.9 million versus the consensus estimate of $609.84 million.

GUIDANCE:

Bruker sees FY2022 EPS of $2.29-$2.33, versus the consensus of $2.29.

For earnings history and earnings-related data on Bruker (BRKR) click here.